Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with Spinal Muscular Atrophy (SMA)
Sun Pharma discontinues work on its experimental skin drug SCD-044 after Phase 2 trial results fall short of goals for treating psoriasis and atopic dermatitis
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Subscribe To Our Newsletter & Stay Updated